Interfant-21: New trial for infants with ALL launched in Belgium
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The BSPHO Scientific Meeting on 20 September featured key insights into pediatric haemato-oncology research. See topics discussed and event photos.
Participate in the e-Quol survey to help enhance digital health tools for young cancer survivors and their loved ones.
The CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.
BSPHO coordinated the care of the young gazan patients from Gaza by paediatric oncology centres across the country.
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
The amendment to the Royal Decree on paediatric oncology which groups patients in a smaller number of reference centres and creates networks to organise parts of the treatment trajectory close to the patient's home is published.
In June 2024, the International Euro Ewing (iEuroEwing) trial was launched to evaluate treatment optimisation in patients with Ewing sarcoma.
A new trial for infants (<1 year) with KMT2A‐rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia launched in Belgium.
The BSPHO Scientific Meeting on 20 September featured key insights into pediatric haemato-oncology research. See topics discussed and event photos.
Participate in the e-Quol survey to help enhance digital health tools for young cancer survivors and their loved ones.
The CAYA policy brief publication outlines key recommendations to improve care and outcomes for young cancer patients.
BSPHO coordinated the care of the young gazan patients from Gaza by paediatric oncology centres across the country.
The BSPHO Clinical Trial Day 2024 was held on 21 June at the Park Inn Hotel in Leuven. Read the event highlights.
The amendment to the Royal Decree on paediatric oncology which groups patients in a smaller number of reference centres and creates networks to organise parts of the treatment trajectory close to the patient's home is published.
In June 2024, the International Euro Ewing (iEuroEwing) trial was launched to evaluate treatment optimisation in patients with Ewing sarcoma.
The first BSPHO Scientific Meeting of 2024 brought together physicians and researchers to discuss paediatric haemato-oncology advancements.
In January 2024, the NORDIC trial launched and will evaluate Cerebellar Mutism Syndrome in children undergoing brain tumour surgery.
In September 2023, ALCL-VBL trial was launched to evaluate Vinblastine treatment for children under 18 with Anaplastic Large Cell Lymphoma.
New booklet by BAYER: 'Detective Didi & Sidekick' - Helping Kids Understand Cancer.
New study launched: FaR-RMS study investigates novel treatments for pediatric and adult Rhabdomyosarcoma patients, aiming to enhance outcomes.
The Belgian Cancer Registry presents its latest publication 'Cancer in children and adolescents in Belgium 2004-2020'.
We are pleased to share Neuroblastoma educational materials developed by the working groups (WG) for patients and their families. Learn more about it and find the material here!
BSPHO coordinated the arrival of 4 Ukrainian children with cancer in Belgium to ensure the best care for patients and their families.